Intrarenal administration of molsidomine, a molecule releasing nitric oxide, reduces renal ischemia-reperfusion injury in rats

American Journal of Transplantation

Volumn 4, Issue 10, 2004, Pages 1605-1613

  Rodriguez Peña, Ana ^a   Garcia Criado, Francisco J ^a   Eleno, Nelida ^a   Arevalo, Miguel ^a   Lopez Novoa, Jose M ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Cell adhesion molecules; Cytokines; Inflammation; Nitric oxide; Oxygen free radicals; Renal ischemia

Indexed keywords

ANTIINFLAMMATORY AGENT; CD31 ANTIGEN; CYTOKINE; DIHYDRALAZINE; GAMMA INTERFERON; HYDRALAZINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MOLSIDOMINE; NITRIC OXIDE; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HEMODYNAMIC MONITORING; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; LIGATION; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURVIVAL RATE;

ANIMALS; CATALASE; CREATININE; CYTOKINES; GLUTATHIONE PEROXIDASE; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; MOLSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONORS; RATS; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; SUPEROXIDES; SURVIVAL;

EID: 4744357845     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00560.x     Document Type: Article

References (39)

1. Singbartl K, Green SA, Ley K. Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J 1998; 14: 48-54.
2. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. J Clin Invest 2000; 99: 2682-2690.
3. Najarian JS, Gillingham KJ, Sutherland DE, Reinsmoen NL, Payne WD, Matas AJ. The impact of the quality of initial graft function on cadaver kidney transplants. Transplantation 1994; 57: 812-816.
4. Grinyo JM. Role of ischemia-reperfusion injury in the development of chronic renal allograft damage. Transplant Proc 2001; 33: 3741-3742.
5. Ketteler M, Border WA, Noble NA. Cytokines and IL-arginine in renal injury and repair. Am J Physiol Renal Physiol 1994; 267: F197-F207.
6. Valdivielso JM, Blantz RC. Acute renal failure: is nitric oxide the bad guy? Antioxid Redox Signal 2002; 4: 925-934.
7. Conger J, Robinette J, Villar A, Raij L, Shultz P. Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J Clin Invest 1995; 96: 631-638.
8. Torras J, Herrero-Fresneda I, Lloberas N, Riera N, Cruzado M, Grinyo JM. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int 2002; 261: 2218-2227.
9. Valdivielso JM, Crespo C, Alonso JR et al. Renal ischemia in the rat stimulates glomerular nitric oxide synthesis. Am J Physiol Regulatory Integrative Comparative Physiol 2001; 280: R771-R779.
10. Shoskes DA, Xie Y, Gonzalez-Cadavid NF. Nitric oxide synthase activity in renal ischemia-reperfusion injury in the rat. Transplantation 1997; 63: 495-500.
11. Furlong B, Henderson AH, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987; 90: 687-692.
12. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181-187.
13. Bath PM. The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro. Eur J Clin Pharmacol 1993; 45: 53-58.
14. De Caterina R, Libby P, Peng HB et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60-68.
15. Linas S, Whittenburg D, Repine JE. Nitric oxide prevents neutrophil-mediated acute renal failure. Am J Physiol Renal Physiol 1997; 272: F48-F54.
16. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR. Leucocytes, cell adhesion molecules and the ischemic acute renal failure. Kidney Int 1997; 51: 1463-1468.
17. Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991; 88: 4651-4655.
18. Sato E, Simpson KL, Grisham MB, Koyama S, Robbins RA. Inhibition of MIP-1alpha-induced human neutrophil and monocyte chemotactic activity by reactive oxygen and nitrogen metabolites. J Lab Clin Med 2000; 135: 161-169.
19. Von Knethen A, Brune B. Activation of peroxisome proliferator-activated receptor gamma by nitric oxide in monocytes/macrophages down-regulates p47phox and attenuates the respiratory burst. J Immunol 2002; 169: 2619-2626.
20. Johnson G, III Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 1991; 19: 244-252.
21. Lieberthal W, Wolf E, Rennke HG, Valeri CR, Levinsky NG. Renal ischemia and reperfusion impair endothelium-dependent vascular relaxation. Am J Physiol Renal Physiol 1989; 256: F894-F900.
22. Conger JD, Robinette J, Schrier RW. Smooth muscle calcium and endothelium-derived relaxing factor in the abnormal vascular responses of acute renal failure. J Clin Invest 1988; 82: 532-537.
23. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281: F887-F899.
24. Rosenkranz B, Winkelmann R, Parnham MJ. Clinical pharmacokinetics of molsidomine. Drug Metab Dispos 1990; 30: 372-384.
25. Feelisch M, Ostrowski J, Noack E. On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol 1989; 14: S13-S22.
26. Garcia-Criado FJ, Eleno N, Santos-Benito F et al. Protective effect of exogenous nitric oxide on the renal function and inflammatory reaction in a model of ischemia-reperfusion. Transplantation 1998; 66: 982-990.
27. Ozturk H, Aldemir M, Buyukbayram H, Dokucu AI, Otcu S. The effects of the nitric oxide donor molsidomine prevent in warm ischemia-reperfusion injury of the rat renal - a functional and histopathological study. Int Urol Nephrol 2001; 32: 601-607.
28. Rodriguez-Peña A, Eleno N, Duwell A et al. Endoglin upregulation during experimental renal interstitial fibrosis. Hypertension 2002; 40: 721-728.
29. Cristol JP, Thiemermann C, Mitchell JA, Walder C, Vane JR. Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites. Br J Pharmacol 1993; 109: 188-194.
30. Dagher F, Pollina RM, Rogers DM, Gennaro M, Ascer E. The value and limitations of 1-arginine infusion on glomerular and tubular function in the ischemic/reperfused kidney. J Vasc Surg 1995; 21: 453-459.
31. Laude K, Thuillez C, Richard V. Peroxynitrite triggers a delayed resistance of coronary endothelial cells against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2002; 283: H1418-H1423.
32. Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide production via a direct action on the NADPH-oxidase. J Clin Invest 1992; 90: 1116-1121.
33. Freels JL, Nelson DK, Hoyt JC et al. Enhanced activity of human IL-10 after nitration in reducing human IL-1 production by stimulated peripheral blood mononuclear cells. J Immunol 2002; 169: 4568-4457.
34. De Meyer GR, Kockx MM, Knaapen MW et al. Nitric oxide donor molsidomine favors features of atherosclerotic plaque stability during cholesterol lowering in rabbits. J Cardiovasc Pharmacol 2003; 41: 970-978.
35. Daemen MA, van de Ven MW, Heineman E, Buurman WA. Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation 1999; 67: 792-800.
36. Deng J, Kohda Y, Chiao H et al. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 2001; 60: 2118-2128.
37. Rodriguez-Peña A, Garcia-Giado FJ, Arévalo M et al. Effect of nitric oxide on VCAM expression in a model of renal ischemia-reperfusion. J Physiol Biochem 1999; 55: 218(abstract).
38. Vergona RA, Agnello A, Hirkaler G, Urbano S, Rosenberger L. Protective effects of hydralazine in a renal ischemia model in the rat. Life Sci 1987; 41: 563-569.
39. Abrahams SL, Hazen RJ, Ayers KM. Sodium azide protects against ischemia-induced acute renal failure in rats. Am J Physiol Renal Physiol 1993; 265: F130-F136.